Therapeutic approach in patients with stable angina

Area of Science:

• Cardiology
• Cardiovascular Medicine
• Public Health

Background:

• The optimal therapeutic strategy for chronic stable ischemic heart disease (CSIHD) among medical, interventional, and surgical options is a significant public health concern.
• Current scientific evidence offers limited guidance for selecting among medical treatment, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG), leading to practice-based decision-making.
• The management of CSIHD, particularly in diabetic patients, presents unique challenges, with surgery traditionally recommended, though PCI outcomes are improving.

Purpose of the Study:

• To discuss existing findings and highlight current experiences in managing chronic stable ischemic heart disease.
• To emphasize the evolving landscape of therapeutic options, including pharmacological advancements and interventional procedures.
• To provide insights into the integrated approach for maximizing patient benefit in CSIHD.

Main Methods:

• Review and discussion of existing scientific evidence and clinical findings related to CSIHD management.
• Highlighting specific experiences and considerations for diabetic patients with CSIHD.
• Analysis of pharmacological therapies and coronary revascularization procedures.

Main Results:

• Evidence-based medicine is often superseded by practice-based medicine in choosing between medical, interventional, and surgical strategies for CSIHD.
• Percutaneous coronary intervention outcomes are significantly improving, even in complex patient groups like diabetics, challenging traditional surgical recommendations.
• Pharmacological therapies are advancing, with distinct drug categories for preventing mortality/myocardial infarction and for symptom/ischemia relief.

Conclusions:

• An integrated approach combining guideline-directed medical therapy with appropriate coronary revascularization is crucial for optimal outcomes in CSIHD.
• The choice of therapy requires careful consideration of individual patient factors, especially in diabetic populations where treatment paradigms are shifting.
• Continued research and evidence generation are needed to refine therapeutic strategies for chronic stable ischemic heart disease.